Lamotrigine ER Titration: Prescribe One 25 mg Tablet, Not Half a 50 mg Tablet
Your prescription of 25 mg nightly (1 whole tablet) for weeks 1-2 is correct and should not be changed to 0.5-1 tablet. The pharmacy's suggestion to start with half a tablet is incorrect for lamotrigine extended-release formulations.
Why Whole Tablets Are Required
Extended-release tablets are specifically formulated to release medication slowly over 24 hours. Splitting or breaking these tablets destroys the extended-release mechanism, leading to:
- Immediate release of the full dose (potential toxicity)
- Loss of steady-state pharmacokinetics
- Unpredictable drug levels
- Increased risk of adverse effects, particularly rash
The FDA labeling 1 lists lamotrigine ER in discrete tablet strengths (25 mg, 50 mg, 100 mg, 200 mg, 250 mg, 300 mg), which are designed to be taken whole, not split.
Your Titration Schedule Is Appropriate
Your prescribed regimen follows standard extended-release titration:
- Weeks 1-2: 25 mg nightly (1 × 25 mg tablet)
- Weeks 3-4: 50 mg nightly (2 × 25 mg tablets OR 1 × 50 mg tablet)
This gradual escalation is critical for minimizing the risk of serious rash, including Stevens-Johnson syndrome 23. Slower titration schedules significantly reduce rash development (P=0.005) 2.
Common Pitfall to Avoid
Never split, crush, or chew extended-release lamotrigine tablets. If dose adjustments are needed, use different tablet strengths or multiple whole tablets to achieve the target dose. The extended-release formulation is designed for once-daily dosing with intact tablets to maintain therapeutic levels while minimizing peak-related side effects 4.
Response to Pharmacy
Inform the pharmacy that:
- The prescription is written correctly as 25 mg (one whole tablet) nightly
- Extended-release tablets must not be split
- The titration follows standard protocols for lamotrigine ER
- If they have concerns about the formulation, they should dispense the 25 mg strength as written